Supernus Pharmaceuticals, Inc.SUPNNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank7
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Percentile
P7
Near historical low
vs 5Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-44.52M-154.5%
2024$81.67M+1649.9%
2023$-5.27M-111.4%
2022$46.12M-46.4%
2021$86.03M-50.5%
2020$173.70M+16.9%
2019$148.57M+2.9%
2018$144.44M+45.1%
2017$99.54M+83.6%
2016$54.22M-